Home › Hologic, Inc. (HOLX) Upgraded at Zacks Investment Research
 

Keywords :   


Hologic, Inc. (HOLX) Upgraded at Zacks Investment Research

2015-12-21 05:46:43| Biotech - Topix.net

The firm currently has a $43.00 target price on the stock. Zacks Investment Research 's price target would indicate a potential upside of 11.46% from the company's previous close.

Tags: research investment upgraded zacks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Public Advisory Number 19A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07'Floodgates open' for legal action against water firms
03.07Atlantic Tropical Weather Outlook
03.07Eastern North Pacific Tropical Weather Outlook
03.07Greece starts six-day working week for some industries
03.07ThaMa-Vet unveils fixed dosage swine syringes
More »